/ database / PPAR-delta Agonist

Cardarine

Also: GW501516

Endurance and fat-loss compound popular despite serious safety concerns.

Evidence

anecdotal

Legal status

research only

Half-life

Short (~hours)

Routes

oral

US-sourcedHPLC testedLot-traceableView this lot's COA →

What it is

Endurance and fat-loss compound popular despite serious safety concerns. Caution: carcinogenicity in long-term rodent studies.

Mechanism

Endurance and fat-loss compound popular despite serious safety concerns.

Outcomes it's matched to

Fat loss
Fat Loss & Body Composition
Reported fat loss benefit in current literature.
STRENGTH
70%
Energy
Energy & Mitochondrial Output
Reported energy benefit in current literature.
STRENGTH
70%

Safety

Educational reference only. Long-term human safety varies; consult a peptide-literate clinician.

Legal context

Banned in sport (non-peptide)

Have questions about this peptide?